278 related articles for article (PubMed ID: 19853913)
1. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
4. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Zhang W; Yang L; Yan Y; Lin J; Qian J
J Cell Mol Med; 2017 Aug; 21(8):1468-1481. PubMed ID: 28452111
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome.
Kang H; Wang X; Gao L; Cen J; Li M; Wang W; Wang N; Li Y; Wang L; Yu L
Eur J Med Res; 2015 Feb; 20(1):16. PubMed ID: 25889027
[TBL] [Abstract][Full Text] [Related]
9. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome.
Wu S; Xie G; Bai R; Wang Y; Zhu P
Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020
[TBL] [Abstract][Full Text] [Related]
10. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF
Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908
[TBL] [Abstract][Full Text] [Related]
11. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative study of calcitonin gene methylation in myelodysplastic syndromes].
Bai R; Wu S; Zhu P; Xue H; Xu Y; Qin X
Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):17-20. PubMed ID: 15622744
[TBL] [Abstract][Full Text] [Related]
13. Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome.
Qian J; Yao DM; Lin J; Wang YL; Han LX; Xu WR; Wu CY
Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):74-81. PubMed ID: 19196380
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
15. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
16. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
[TBL] [Abstract][Full Text] [Related]
18. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
19. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.
Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T
Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.
Chen H; Wu S
Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
